Pharma Stock to Watch! FIIs & DIIs Bet Big as This Drugmaker Launches a New Eye Treatment in the US! Pharma Stock to Watch! FIIs & DIIs Bet Big as This Drugmaker Launches a New Eye Treatment in the US! FDA-Approved & Ready! This Pharma Giant Targets a USD 113 Million Market! Pushkar Shinde / Friday, February 14, 2025 / Article rating: 3.3 FDA-Approved & Ready! This Pharma Giant Targets a USD 113 Million Market!
114 Per Cent Returns: Multibagger Pharma Company Reports 81 Per Cent PAT Growth; Sales Up 9 Per Cent 114 Per Cent Returns: Multibagger Pharma Company Reports 81 Per Cent PAT Growth; Sales Up 9 Per Cent The company's net profit surged 81 per cent year-on-year (YoY) to Rs 276.4 crore, compared to Rs 152.9 crore in Q3 FY24. Manoj Reddy Sama / Thursday, February 13, 2025 / Article rating: 3.8 Revenue grew by 9 per cent YoY to Rs 2,245.4 crore, up from Rs 2,052.9 crore in the corresponding quarter last year.
Pharma Major Shares Rebound from Lows; Firm Reports 39.5 per cent Profit Growth Pharma Major Shares Rebound from Lows; Firm Reports 39.5 per cent Profit Growth The company reported a net income of Rs 8,552 crore, marking a 39.5 per cent YoY growth. Total sales increased 10.6 per cent YoY to Rs 56,186 crore from Rs 50,799 crore in Q3 FY24 Abhishek Wani / Wednesday, February 12, 2025 / Article rating: 5.0 The company reported a net income of Rs 8,552 crore, marking a 39.5 per cent YoY growth. Total sales increased 10.6 per cent YoY to Rs 56,186 crore from Rs 50,799 crore in Q3 FY24
Pharma Penny Stock Under Rs 50 Jumps Over 10 Per Cent On January 28; PAT Jumps Over 30 Per Cent in Q3FY25 Pharma Penny Stock Under Rs 50 Jumps Over 10 Per Cent On January 28; PAT Jumps Over 30 Per Cent in Q3FY25 From Rs 43.42 per share (52-week low) to Rs 48.55 per share, the stock is up by 11.8 per cent. Kiran Shroff / Tuesday, January 28, 2025 / Article rating: 4.2 From Rs 43.42 per share (52-week low) to Rs 48.55 per share, the stock is up by 11.8 per cent.
This Pharma Stock Declines 4.86 per cent; Board Approves Rs 570 Crore Fundraise, Know the Stock Outlook Here This Pharma Stock Declines 4.86 per cent; Board Approves Rs 570 Crore Fundraise, Know the Stock Outlook Here The Board of Directors approved the issuance of commercial papers worth Rs 570 crore on a private placement basis Abhishek Wani / Monday, January 27, 2025 / Article rating: 3.3 The Board of Directors approved the issuance of commercial papers worth Rs 570 crore on a private placement basis
33 Per Cent Jump In PAT: Pharma Penny Stock Under Rs 60 Jumps Over 5 Per Cent On January 23 33 Per Cent Jump In PAT: Pharma Penny Stock Under Rs 60 Jumps Over 5 Per Cent On January 23 From Rs 43.35 per share (52-week low) to Rs 51.25 per share, the stock is up by 18.2 per cent. Kiran Shroff / Thursday, January 23, 2025 / Article rating: 4.6 From Rs 43.35 per share (52-week low) to Rs 51.25 per share, the stock is up by 18.2 per cent.
Pharma Penny Stock Under Rs 55 in Focus After Receiving GAIN Certification; Complete Details Inside Pharma Penny Stock Under Rs 55 in Focus After Receiving GAIN Certification; Complete Details Inside From Rs 43.42 per share (52-week low) to Rs 51.30 per share, the stock is up by 18.15 per cent. Kiran Shroff / Wednesday, January 8, 2025 / Article rating: 4.0 From Rs 43.42 per share (52-week low) to Rs 51.30 per share, the stock is up by 18.15 per cent.
Pharma Stock Soars 4 per cent Following FDA Approval and Strategic Partnership with Leading US Company Pharma Stock Soars 4 per cent Following FDA Approval and Strategic Partnership with Leading US Company FDA Nod for Key Diabetes Treatment Boosts Market Confidence and Stock Performance Pushkar Shinde / Tuesday, January 7, 2025 / Article rating: 5.0 FDA Nod for Key Diabetes Treatment Boosts Market Confidence and Stock Performance
Pharma Stock Jumps 4.5 per cent After Japan’s Nod for Injectable Biosimilar Pharma Stock Jumps 4.5 per cent After Japan’s Nod for Injectable Biosimilar A key injectable biosimilar gets the green light from Japan, driving a 4.5 per cent surge in stock price. Pushkar Shinde / Tuesday, January 7, 2025 / Article rating: 5.0 A key injectable biosimilar gets the green light from Japan, driving a 4.5 per cent surge in stock price.
CDMO Company's Shares Surge Over 12 Per Cent in Two Trading Sessions; Here’s Why CDMO Company's Shares Surge Over 12 Per Cent in Two Trading Sessions; Here’s Why The company's shares surged 10 per cent to hit the upper circuit at Rs 668.10 on the BSE. This marked the second consecutive session of gains for the stock Manoj Reddy Sama / Friday, December 27, 2024 / Article rating: 5.0 Under the agreement, Akums will receive an upfront payment of EUR 100 million (Rs 880 crore) to fund product development and secure European regulatory approvals for its oral liquid manufacturing facility.